Pay in 4 interest-free payments of $6.42 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
2020 [citato 1 gennaio 7d.C.];14(4):28992
Unlike existing GLP-1 receptor agonists such as semaglutide (Wegovy, Ozempic) or dual agonists like tirzepatide (Mounjaro, Zepbound), Retatrutide is a triple agonist that targets GLP-1, GIP, and glucagon receptors simultaneously
This product is best applied to very damp skin
The SURPASS clinical trials included patients with stable cardiovascular disease, though those with unstable or severe cardiovascular conditions were typically excluded
The drug has been undergoing clinical trials for the treatment of hypoactive sexual desire disorder and erectile dysfunction
If you begin GLP-1 therapy, contact your GP promptly if you experience severe abdominal pain (which could indicate pancreatitis), persistent nausea or vomiting, symptoms of thyroid problems (such as a lump in the neck, hoarseness, or difficulty swallowing), or any other concerning symptoms
US$ 22.45
US$ 24.83
US$ 20.79
US$ 23.94
US$ 21.58
